Xilio Development Valuation

XLO Stock  USD 0.72  0.01  1.37%   
Xilio Development is undervalued. Xilio Development maintains a prevalent Real Value of $1.53 per share. The last-minute price of the company is $0.72. Our model calculates the value of Xilio Development from examining the company fundamentals such as Return On Asset of -0.38, shares outstanding of 51.78 M, and Operating Margin of (4.73) % as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
0.72
Please note that Xilio Development's price fluctuation is abnormally volatile at this time. Calculation of the real value of Xilio Development is based on 3 months time horizon. Increasing Xilio Development's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Xilio Development is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Xilio Stock. However, Xilio Development's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value.
Historical Market  0.72 Real  1.53 Hype  0.72 Naive  0.63
The intrinsic value of Xilio Development's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Xilio Development's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
1.53
Real Value
11.32
Upside
Estimating the potential upside or downside of Xilio Development helps investors to forecast how Xilio stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Xilio Development more accurately as focusing exclusively on Xilio Development's fundamentals will not take into account other important factors:
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.690.720.75
Details
Hype
Prediction
LowEstimatedHigh
0.040.7210.51
Details
Naive
Forecast
LowNext ValueHigh
0.010.6310.41
Details

Xilio Development Total Value Analysis

Xilio Development is at this time expected to have company total value of (44.28 M) with market capitalization of 37.54 M, debt of 8.14 M, and cash on hands of 159.41 M. The negative valuation of Xilio Development may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial commitments of the company both on and off balance sheet. Investors should carefully check all of the Xilio Development fundamentals.
  Takeover PriceMarket CapDebt ObligationsCash
(44.28 M)
37.54 M
8.14 M
159.41 M

Xilio Development Investor Information

About 46.0% of the company outstanding shares are owned by insiders. The book value of Xilio Development was at this time reported as 0.21. The company recorded a loss per share of 0.65. Xilio Development had not issued any dividends in recent years. Based on the key indicators related to Xilio Development's liquidity, profitability, solvency, and operating efficiency, Xilio Development is not in a good financial situation at this time. It has a very high odds of going through financial crisis in August.

Xilio Development Asset Utilization

The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Xilio Development has an asset utilization ratio of 8.93 percent. This suggests that the Company is making $0.0893 for each dollar of assets. An increasing asset utilization means that Xilio Development is more efficient with each dollar of assets it utilizes for everyday operations.

Xilio Development Ownership Allocation

Xilio Development retains a total of 51.78 Million outstanding shares. Xilio Development owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.

Xilio Development Profitability Analysis

The company reported the last year's revenue of 6.34 M. Reported Net Loss for the year was (58.24 M) with profit before taxes, overhead, and interest of 9.27 M.

About Xilio Development Valuation

We use absolute and relative valuation methodologies to arrive at the intrinsic value of Xilio Development. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Xilio Development based exclusively on its fundamental and basic technical indicators. By analyzing Xilio Development's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Xilio Development's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Xilio Development. We calculate exposure to Xilio Development's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Xilio Development's related companies.
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients. Xilio Therapeutics, Inc. was founded in 2016 and is headquartered in Waltham, Massachusetts. Xilio Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 74 people.

Xilio Development Growth Indicators

Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding53.5 M
When determining whether Xilio Development offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Xilio Development's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Xilio Development Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Xilio Development Stock:
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xilio Development. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
To learn how to invest in Xilio Stock, please use our How to Invest in Xilio Development guide.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xilio Development. If investors know Xilio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xilio Development listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xilio Development is measured differently than its book value, which is the value of Xilio that is recorded on the company's balance sheet. Investors also form their own opinion of Xilio Development's value that differs from its market value or its book value, called intrinsic value, which is Xilio Development's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xilio Development's market value can be influenced by many factors that don't directly affect Xilio Development's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xilio Development's value and its price as these two are different measures arrived at by different means. Investors typically determine if Xilio Development is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xilio Development's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.